Emi Nishimura

Effectiveness and safety of weekly paclitaxel and cetuximab as a salvage chemotherapy following immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: A multicenter clinical study

M. Masuda, Y. Kuratomi, R. Yasumatsu, 2022, PloS one.